- Breakthrough in fight against world’s deadliest cancer – new drug shrunk up to 70% of pancreatic tumors in lab Daily Mail
- Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy Nature.com
- Investigational therapeutic shows promise in preclinical pancreatic cancer model Medical Xpress
- New treatment for pancreatic cancer patients now available in the Upstate WSPA 7News
- Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins GlobeNewswire
Tag Archives: drug
Weight-loss drug Wegovy offers benefits for people with diabetes and common form of heart failure, study finds – CNN
- Weight-loss drug Wegovy offers benefits for people with diabetes and common form of heart failure, study finds CNN
- Novo’s Wegovy Aids Heart Failure Patients With Diabetes in Study Bloomberg
- Wegovy’s heart benefits are not just linked with weight loss, new study suggests MarketWatch
- Study shows Wegovy easing heart failure symptoms for patients with diabetes—helpful to Novo Nordisk as it makes case insurers should pay for the weight-loss medication Fortune
- Positive trial results set up obesity drug Wegovy for use against heart failure STAT
FDA approves new drug that may help stop and even reverse a rare, fatal condition that doctors call a ‘ticking time bomb’ – CNN
- FDA approves new drug that may help stop and even reverse a rare, fatal condition that doctors call a ‘ticking time bomb’ CNN
- FDA approves Merck’s drug for rare, deadly lung condition CNBC
- FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1) Merck
- FDA Approves Sotatercept, First-in-Class Treatment for Adults With PAH AJMC.com Managed Markets Network
- Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives The Wall Street Journal
Anti-anxiety drug prescribed to 8million Brits ‘linked to 3,400 deaths in 5 years’ – The Mirror
- Anti-anxiety drug prescribed to 8million Brits ‘linked to 3,400 deaths in 5 years’ The Mirror
- I’m stuck on the ‘anxiety’ drug pregabalin The Telegraph
- Anxiety drug pregabalin killed my son — and hundreds more are dying from it The Times
- Inside the UK’s battle with pregabalin: How addiction fears over opioids and benzos left country sleepwalking towards unfolding fiasco with ‘Valium on steroids’ – as map reveals areas where up to one in 25 residents are given powerful anti-anx Daily Mail
- Pregabalin ‘robbed me of a life and stopped me having kids’, woman who lived her whole life with chronic pain reveals LBC
Ozempic, the happy drug? Study suggests weight-loss medications could reduce depression, anxiety – Fox News
- Ozempic, the happy drug? Study suggests weight-loss medications could reduce depression, anxiety Fox News
- Can Ozempic Treat Depression? Obesity Drugs May Help Mental Health Bloomberg
- Weight-Loss Drugs Like Wegovy Now Linked to Lower Depression Risk Healthline
- Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database – BMC Medicine BMC Medicine
- Popular weight loss drugs connected with lower rates of anxiety, depression TMJ4 News
CDC Report Indicates Teens Are Seeking To Escape Worries And Stress Through Drug Use – HuffPost
- CDC Report Indicates Teens Are Seeking To Escape Worries And Stress Through Drug Use HuffPost
- Stress is a key factor driving some teens to drugs and alcohol, CDC study warns CNN
- Characteristics of Alcohol, Marijuana, and Other Drug Use Among Persons Aged 13–18 Years Being Assessed for Substance Use Disorder Treatment — United States, 2014–2022 | MMWR CDC
- Recent Trends in Mental Health and Substance Use Concerns Among Adolescents | KFF KFF
- Motivations for substance use in teens mainly linked to reducing stress, study finds Medical Xpress
Sofia Vergara and Netflix sued by family of Griselda Blanco ahead of miniseries about drug lord – CBS News
- Sofia Vergara and Netflix sued by family of Griselda Blanco ahead of miniseries about drug lord CBS News
- Sofia Vergara’s ‘Griselda’: Son of real ‘Cocaine Godmother’ calls new series ‘disrespectful’ Fox News
- Griselda TV review — Sofía Vergara brings badass brio as a ruthless drug lord Financial Times
- Sofía Vergara transforms herself in ‘Griselda’ and leaves self-doubt behind Yahoo Entertainment
- Netflix is being sued by the only surviving son of drug lord Griselda as he tries to block premiere of new show based on her life Gamesradar
As Zepbound dominates headlines as a new obesity-fighting drug, a nutritionist warns that weight loss shouldn’t be the only goal – The Conversation Indonesia
- As Zepbound dominates headlines as a new obesity-fighting drug, a nutritionist warns that weight loss shouldn’t be the only goal The Conversation Indonesia
- What do studies reveal about recent trend of weight loss drugs? WKYC.com
- Demand on weight loss drugs puts heart patient at risk WJXT News4JAX
- As another obesity-fighting drug takes center stage, a nutrition expert warns that weight loss shouldn’t be the only goal The Conversation Indonesia
- As another obesity-fighting drug takes center stage, a nutrition expert discusses weight loss Medical Xpress
South Korean celebrities attend Lee Sun-kyun’s memorial; police defend ‘Parasite’ actor’s drug probe – South China Morning Post
- South Korean celebrities attend Lee Sun-kyun’s memorial; police defend ‘Parasite’ actor’s drug probe South China Morning Post
- Death of ‘Parasite’ star puts spotlight on pressures facing South Korean celebrities CNN
- South Korean actor Lee Sun-kyun of Oscar-winning film ‘Parasite’ is found dead The Associated Press
- Death of Lee Sun-kyun of ‘Parasite’ Highlights South Korea’s Drug Crackdown The New York Times
- Lee Sun-kyun is 5th Korean star to die of suspected suicide; 12 have perished in tragedies in recent years The Mercury News
Eli Lilly’s experimental drug lowers risk of heart disease by 94%: study – New York Post
- Eli Lilly’s experimental drug lowers risk of heart disease by 94%: study New York Post
- Eli Lilly’s Heart Drug Lepodisiran Cuts Lipoprotein Lp(a) for Year in Study Bloomberg
- Trial Shows a Single Dose of an Experimental Therapy Reduces Lipoprotein(a), an Important Heart Disease Risk Factor, More than 94% for Nearly a Year Cleveland Clinic Newsroom
- Sustained Reductions in Lp(a) Achieved With Novel siRNA Drug Medscape
- One dose of experimental therapy reduced lipoprotein(a) more than 94% for nearly a year American Heart Association
- View Full Coverage on Google News